Fundz

Fundz Deep Dive

Everything you need to win Avant Genomics — in one platform.

Who to reach, what to say, and why now on Avant Genomics — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Avant Genomics — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Avant Genomics raises over $3M to enhance R&D and manufacturing capacity, backed by TitletownTech and others.

PRIVATEMay 13, 2026•about 1 month ago

Amount Raised

$3 Million

Round Type

seed

Charlottesville

Investors

Family OfficesAdditional Angel InvestorsGlobal Impact FundCav AngelsVirginia Venture PartnersHalyard VenturesTitletown Tech

Description

Avant Genomics, based in Charlottesville, VA, specializes in automated liquid biopsy preparation for cancer detection. The company raised over $3M in funding from investors including TitletownTech and Halyard Ventures. The funds will be used for R&D initiatives and expanding its team. Avant Genomics aims to improve precision oncology through its Avant Source platform.

Company Information

Company

Avant Genomics

Location

Charlottesville, Virginia, United States

About

Avant Genomics is a biotechnology company that specializes in fully-automated liquid biopsy sample preparation for precision cancer detection. Founded as a spin-out from the University of Virginia, the company develops a platform called Avant Source aimed at improving precision oncology. It focuses on supporting R&D and enhancing its manufacturing capabilities. The leadership team includes CEO Rachelle Turiello and COO Renna Nouwairi.

Related People

Suggested for you
3 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

1 more contact · See plans

Predictive Intelligence
Strategic

ML-powered predictions for Avant Genomics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Avant Genomics? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan